PHARMACEUTICAL COMPOSITION Russian patent published in 2017 - IPC C07D231/20 A61K31/415 A61P29/00 A61P35/00 A61P25/28 

Abstract RU 2606510 C2

FIELD: pharmaceutics.

SUBSTANCE: present invention relates to compounds of formula (I), in which one of R1a and R1b is hydrogen and the other is methyl; or R1a and R1b together form a cyclopropyl ring; R2 denotes methyl or monofluoromethyl, difluoromethyl or trifluoromethyl; R3 denotes methyl; R4 denotes hydrogen, halogen, monofluoromethyl, difluoromethyl, trifluoromethyl, methyl, methoxy, monofluoromethoxy, difluoromethoxy or trifluoromethoxy; R5 denotes hydrogen, halogen, monofluoromethyl, difluoromethyl, trifluoromethyl, methyl, methoxy, monofluoromethoxy, difluoromethoxy or trifluoromethoxy; R6 is hydrogen; R7 means hydrogen; and X denotes oxygen; or pharmaceutically acceptable salts thereof.

EFFECT: compound of formula (I) inhibit the transmission of PGE/EP4 signal and can be used for treating autoimmune pathologies, such as rheumatoid arthritis, multiple sclerosis, psoriasis, cancer and other; invention also relates to pharmaceutical compositions containing these compounds, and methods for using them in the case of individuals in need of treatment.

50 cl, 2 dwg, 3 tbl, 113 ex

Similar patents RU2606510C2

Title Year Author Number
DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USING THEM 2010
  • Shrimpf Majkl R.
  • Sippi Kevin B.
RU2549551C2
HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 RECEPTOR) 2008
  • Zhenest Ehrve
  • Sauer Dehril
  • Braje Vil'Frid
  • Amberg Vil'Khel'M
  • Metsler Mario
  • Bakker Margareta Khenrika Marija
RU2479577C2
SUBSTITUTED CHROMANS 2015
  • Kim Filip R.
  • Van Syutsin
  • Sirl Kseniya B.
  • Lyu Bo
  • Eung Min S.
  • Altenbech Robert Dzh.
  • Vojt Erik
  • Bogdan Endryu
  • Kenig Dzhon R.
  • Greszler Stiven N.
RU2718060C2
ARYLSULPHONAMIDE CCR3 ANTAGONISTS 2010
  • Laj Taj Vehj
  • Forrester Dzhared Ehndrju
RU2539591C2
(ALPHA-SUBSTITUTED ARALKYLAMINO- AND HETEROARYLALKYLAMINO)PYRIMIDINYL- AND 1,3,5-TRIAZINYLBENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF IN TREATING PROLIFERATIVE DISEASES 2012
  • Braun S. Devid
  • Mettyuz Devid Dzh.
RU2608742C2
PYRAZOLYL-SUBSTITUTED BENZENESULFONEAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF TREATMENT OF PATIENTS WITH INFLAMMATION OR INFLAMMATION-ASSOCIATED DISEASES 1994
  • Dzhon Dzh.Tolli
  • Tomas D.Penning
  • Pol' V.Kollinz
  • Donal'D Dzh.Rodzher
  • Dzhejms V.Malecha
  • Dzhuli M.Mijasiro
  • Stefen R.Bertensho
  • Ish K.Kkhanna
  • Mehtt'Ju Dzh.Grehnets
  • Ronal'D S.Rodzhers
  • Dzheffri S.Karter
  • Stefen Kh.Dokter
  • Stella S.Ju
RU2139281C1
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES 2018
  • Wang, Bing
  • Chao, Qi
RU2805308C2
CHEMICAL COMPOUNDS-759 2008
  • Dejvis Odri
  • Ioannidis Stefanos
  • Lamb Mishell'
  • Su Mehj
  • Van Tao
  • Chzhan Khajtszun'
RU2481348C2
NEW COMPOUND OF BENZIMIDAZOLONE AND ITS PHARMACEUTICAL USE 2018
  • Mizushima, Shingo
  • Watanabe, Masaki
  • Iwamoto, Kohei
  • Urashima, Kuniko
RU2803938C2
TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS 2008
  • Lju Gan
  • Sin' Chzhili
  • Kim Filip R.
  • Sauehrs Ehndrju Dzh.
RU2486186C2

RU 2 606 510 C2

Authors

Spajvi Mark

Satokh Takasi

Karlson Dzhonatan Erik

Dates

2017-01-10Published

2011-09-12Filed